Cyproheptadine
Back to searchMolecule Structure
Scientific Name
Cyproheptadine
Description of the Drug
Cyproheptadine is a combined serotonin and histamine antagonist used in the treatment of allergic symptoms, for appetite stimulation, and off-label in the treatment of serotonin syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00434
http://www.drugbank.ca/drugs/DB00434
Brand Name(s)
Not Available
Company Owner(s)
Vitarine Pharmaceuticals Inc, Halsey Drug Co Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Kv Pharmaceutical Co, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Lyne Laboratories Inc, Boscogen Inc, Merck And Co Inc, Mountain Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4021 | |
PharmGKB | PA164749366 | |
Human Metabolome Database | HMDB0014578 | |
DrugBank | DB00434 | |
PubChem: Thomson Pharma | 14751189 | |
PubChem | 2913 | |
Mcule | MCULE-3352282545 | |
LINCS | LSM-5419 | |
Nikkaji | J5.419D | |
PDBe | C7H | |
BindingDB | 50017721 | |
EPA CompTox Dashboard | DTXSID8022872 | |
DrugCentral | 765 | |
Brenda | 7429 | |
Guide to Pharmacology | 277 | |
rxnorm | CYPROHEPTADINE | CYPROHEPTADINE HYDROCHLORIDE |
KEGG Ligand | C06935 | |
ChEBI | 4046 | |
ZINC | ZINC000000968264 |